SCHEMBL17060912

SCHEMBL17060912

[N-]=[N+]=NCc1ccc(NC(=O)O)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P4HTM Q9NXG6 5/20 0.37
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ KCNQ3 O43525 1/20 0.33
▸ KCNQ2 O43526 1/20 0.33
▸ HDAC8 Q9BY41 3/20 0.33
▸ HDAC3 O15379 2/20 0.33
▸ NCOR2 Q9Y618 1/20 0.33
▸ AGPAT2 O15120 1/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ NPC1 O15118 3/20 0.32
▸ RAB9A P51151 3/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ PTPN2 P17706 1/20 0.32
▸ PTPN1 P18031 1/20 0.32
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17060910 1.00 P4HTM (0.37) P4HTMMEN1KMT2AMAPTKDM4E
SCHEMBL22122701 0.85 CYP1A1 (0.46) MEN1KMT2AMAPTKDM4EHDAC8
SCHEMBL22122705 0.83 SMN1; SMN2 (0.41) MEN1KMT2AMAPTKDM4EHDAC8
SCHEMBL16562887 0.80 NAMPT (0.43) HDAC8
SCHEMBL22122715 0.80 SMN1; SMN2 (0.43) HDAC8HDAC3NCOR2SMN1; SMN2HDAC4
SCHEMBL15285101 0.77 P4HA1 (0.46) P4HTMMAPTHSD17B10ALDH1A1
SCHEMBL28960892 0.76 HDAC8 (0.46) HDAC8HDAC3NCOR2NPC1HDAC1
SCHEMBL1900631 0.76 PDE7A (0.41) P4HTMMEN1KMT2AMAPTKDM4E
SCHEMBL28544744 0.76 HDAC8 (0.43) MEN1KMT2AMAPTKDM4EHDAC8
SCHEMBL30728587 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11067580-B2 Compounds and methods for conjugation of biomolecules Life Technologies Corporation (US) 2021-07-20 — — US disclosed
US-20200333351-A1 Compounds and Methods for Conjugation of Biomolecules Life Technologies Corporation 2020-10-22 — — US disclosed
US-10648985-B2 Compounds and methods for conjugation of biomolecules Life Technologies Corporation (US) 2020-05-12 — — US disclosed
US-20190079095-A1 COMPOUNDS AND METHODS FOR CONJUGATION OF BIOMOLECULES Life Technologies Corporation 2019-03-14 — — US disclosed
EP-2966061-A1 COMPOUNDS AND METHODS FOR CONJUGATION OF BIOMOLECULES Life Technologies Corporation (US) 2016-01-13 — — EP disclosed
EP-2681196-B1 COMPOUNDS AND METHODS FOR CONJUGATION OF BIOMOLECULES LIFE TECHNOLOGIES CORP (US) 2015-09-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190079095-A1 COMPOUNDS AND METHODS FOR CONJUGATION OF BIOMOLECULES LIG3, LIG1, HLCS P4HTM 3143/4885MEN1 404/4885KMT2A 2092/4885
US-20200333351-A1 Compounds and Methods for Conjugation of Biomolecules LIG3, LIG1, HLCS P4HTM 3143/4885MEN1 404/4885KMT2A 2092/4885
US-11067580-B2 Compounds and methods for conjugation of biomolecules LIG3, LIG1, HLCS P4HTM 3143/4885MEN1 404/4885KMT2A 2092/4885
US-10648985-B2 Compounds and methods for conjugation of biomolecules LIG3, LIG1, HLCS P4HTM 3143/4885MEN1 404/4885KMT2A 2092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback